Breast lumps medical therapy

Breast lumps Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Breast lumps from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Breast lumps medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Breast lumps medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Breast lumps medical therapy
on Breast lumps medical therapy
Breast lumps medical therapy in the news
Blogs on Breast lumps medical therapy
Directions to Hospitals Treating Breast lumps
Risk calculators and risk factors for Breast lumps medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Management and medical therapy of breast lumps depends on women's age (age> 40 or age <40) and mammography results in women aged > 40 years. In women aged > 40 years; no further evaluation is needed in case of clearly benign mass in mammography; however, ultrasound imaging is required for the rest of the findings mammography. Approach to breast lumps in women >40 years is depended on breast imaging reporting and data systems (BI-RADS) stages. Medical therapy of breast lumps in women< 40 years is depended on ultrasound results and BI-RADS categories.

Breast lumps medical therapy

Management of breast lumps:

• women aged >40 years with palpable mass:
  • Diagnostic mammography is considered as the first step.
  • If the last screening test is related to more than previous 6 months, both breast mammography is required to rule out occult malignancy.
  • No further evaluation is needed in case of clearly benign mass in mammography.
  • Ultrasound imaging is required for the rest of cases appeared in mammography.
    • Stereotactic biopsy is recommended in negative ultrasound findings addition to suspicious mammographic results.
• Women aged< 40 years with palpable mass:
  • Ultrasound or mammography is suggested for initial management of women aged between 30 to 39 years.
  • Ultrasound is the first step for women< 30 years presenting with palpable mass.

Approach to breast lumps in women aged >40 years based on mammographic results:

• If mammographic results become negative, the next step is targeted ultrasound.
  • Negative ultrasound results considered as breast imaging reporting and data system (BI-RADS) 1, then clinical follow-up is needed.
  • Benign ultrasound results considered as BI-RADS 2, then clinical follow-up is needed.
  • Probably benign results considered as BI-RADS 3, then ultrasound short interval follow-up is needed.
  • Suspicious ultrasound results considered as BI-RADS 4 or 5, then core-needle biopsy is needed.
• If mammographic results show only fatty tissue:
  • Considered as BI-RADS 1, then clinical follow-up is needed.
• If mammographic results show benign mass:
  • Considered as BI-RADS 2, then clinical follow-up
• If mammographic results are in favor of probably benign lumps, the next step is targeted ultrasound.
  • Negative ultrasound results considered as BI-RADS 3, then mammographic short interval follow-up is required.
  • Benign ultrasound results considered as BI-RADS 2, then clinical follow-up is required.
  • Probably benign ultrasound results considered as BI-RADS 3, then ultrasound short interval follow-up.
  • Suspicious ultrasound results is considered as BI-RADS 4 or 5, then core needle biopsy is required.
• If mammographic result is in favor of suspicious lesion, the next step is ultrasound to determine biopsy plan.
  • Considered as BI-RADS 4 or 5, then core needle biopsy is required.

Approach to breast lumps in women aged <40 years based on targeted ultrasound findings:

• If ultrasound results become negative, there are two approaches:
  • Considered as BI-RADS 1, then clinical follow-up is required.
  • Perform diagnostic mammography:
    • Negative results are in favor of BI-RADS 1, then clinical follow-up is required.
    • Benign results are considered as BI-RADS 2, then clinical follow-up is required.
    • Probably benign results considered as BI-RADS 3, Mammographic short interval follow-up is required.
    • Suspicious results considered as BI-RADS 4 or 5, then core needle biopsy is required.
• If ultrasound results show benign findings:
  • Considered as BI-RADS 2, then clinical follow-up is required.
• If ultrasound results show probably benign findings:
  • Considered as BI-RADS 3, then short interval follow-up is required.
• If ultrasound results become suspicious:
  • Considered as BI-RADS 4 or 5, then core needle biopsy is required.

References

Template:WikiDoc Sources